AMWL
American Well CorporationNYSEHealthcare$5.57+1.27%ClosedMarket Cap: $92.2M
As of 2026-04-07
Valuation
P/E (TTM)
—
PEG
—
P/B
0.39
P/S
0.37
EV/EBITDA
1.20
DCF Value
$-95.69
FCF Yield
-71.6%
Div Yield
0.0%
Margins & Returns
Gross Margin
53.3%
Operating Margin
-42.2%
Net Margin
-38.4%
ROE
-35.9%
ROA
-29.6%
ROIC
-41.4%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q4 2025 | $55.3M | 51.2% | $-25.2M | $-24.9M | $-1.52 | — |
| FY 2025 | $249.3M | 53.3% | $-105.3M | $-95.7M | $-5.96 | — |
| Q3 2025 | $56.3M | 52.4% | $-29.3M | $-32.4M | $-2.00 | — |
| Q2 2025 | $70.9M | 56.1% | $-20.4M | $-19.7M | $-1.24 | — |
| Q1 2025 | $66.8M | 52.8% | $-30.4M | $-18.7M | $-1.19 | — |
| Q4 2024 | $71.0M | 48.4% | $-42.8M | $-42.7M | $-2.77 | — |
| FY 2024 | $254.4M | 38.9% | $-217.5M | $-208.1M | $-13.88 | — |
| Q3 2024 | $61.0M | 37.2% | $-47.4M | $-43.5M | $-2.87 | — |
| Q2 2024 | $62.8M | 37.4% | $-52.4M | $-49.9M | $-3.36 | — |
| Q1 2024 | $59.5M | 30.9% | $-75.0M | $-72.1M | $-4.93 | — |
| Q4 2023 | $70.7M | 33.7% | $-57.0M | $-48.6M | $-3.37 | — |
| FY 2023 | $259.0M | 36.6% | $-692.1M | $-675.2M | $-47.50 | — |